
Neurocrine Biosciences, Inc.
USD179.05
+6.05 (+3.50%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$174.77
Prev. Close
$173.00
Day Low
$174.50
Day High
$179.05
52W Low
$122.14
52W High
$181.18
Market Cap
$18.00B
Volume
1.24M
| 29 May 2026 |
| RBC Capital |
| Outperform |
| Outperform |
| maintain |
| 8 May 2026 | JP Morgan | Overweight | Overweight | maintain |
| 7 May 2026 | Truist Securities | Buy | Buy | maintain |
| 6 May 2026 | Citigroup | Buy | Buy | maintain |
| 6 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 6 May 2026 | Morgan Stanley | Equal Weight | Equal Weight | maintain |
| 6 May 2026 | Wedbush | Outperform | Outperform | maintain |